CPC A61K 31/12 (2013.01) [A61K 31/192 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/43 (2013.01); A61K 31/575 (2013.01); A61K 31/58 (2013.01); A61K 31/7036 (2013.01); A61K 38/14 (2013.01); A61P 31/04 (2018.01); A61K 45/06 (2013.01)] | 20 Claims |
1. A method for suppressing growth of methicillin-resistant Staphylococcus aureus (MRSA), comprising contacting the MRSA with kuraridin in a concentration of about 1-4 μg/ml and epicatechin gallate (ECG) in a concentration of about 0.25-8 μg/ml, optionally further with an antibiotic in an effective amount.
|